Related references
Note: Only part of the references are listed.Clinical and molecular insights into BCG immunotherapy for melanoma
M. Kremenovic et al.
JOURNAL OF INTERNAL MEDICINE (2020)
PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
Takahiro Kamada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update
Marko Babjuk et al.
EUROPEAN UROLOGY (2019)
Cationized liposomal keto-mycolic acids isolated from Mycobacterium bovis bacillus Calmette-Guerin induce antitumor immunity in a syngeneic murine bladder cancer model
Takayuki Yoshino et al.
PLOS ONE (2019)
NK cells inhibit anti-Mycobacterium bovis BCG T cell responses and aggravate pulmonary inflammation in a direct lung infection mouse model
Dongfang Wang et al.
CELLULAR MICROBIOLOGY (2018)
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments
Jong W. Yu et al.
PLOS ONE (2018)
The Role of Type 1 Conventional Dendritic Cells in Cancer Immunity
Jan P. Boettcher et al.
TRENDS IN CANCER (2018)
Cancer immunotherapy: the beginning of the end of cancer?
Sofia Farkona et al.
BMC MEDICINE (2016)
Critical Role for CD103+/CD141+ Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
Edward W. Roberts et al.
CANCER CELL (2016)
Response to Programmed Cell Death-1 Blockade in a Murine Melanoma Syngeneic Model Requires Costimulation, CD4, and CD8 T Cells
Blanca Homet Moreno et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Systemic Immunotherapy of Non-Muscle Invasive Mouse Bladder Cancer with Avelumab, an Anti-PD-L1 Immune Checkpoint Inhibitor
Amanda J. Vandeveer et al.
CANCER IMMUNOLOGY RESEARCH (2016)
Cancer immunotherapy: harnessing the immune system to battle cancer
Yiping Yang
JOURNAL OF CLINICAL INVESTIGATION (2015)
Investigation of factors affecting in vitro doxorubicin release from PEGylated liposomal doxorubicin for the development of in vitro release testing conditions
Hiroko Shibata et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens
Matthew M. Gubin et al.
NATURE (2014)
The mechanism of action of BCG therapy for bladder cancer-a current perspective
Gil Redelman-Sidi et al.
NATURE REVIEWS UROLOGY (2014)
MCL and Mincle: C-type lectin receptors that sense damaged self and pathogen-associated molecular patterns
Mark B. Richardson et al.
FRONTIERS IN IMMUNOLOGY (2014)
C-type Lectin MCL Is an FcRγ-Coupled Receptor that Mediates the Adjuvanticity of Mycobacterial Cord Factor
Yasunobu Miyake et al.
IMMUNITY (2013)
Liposome: classification, preparation, and applications
Abolfazl Akbarzadeh et al.
NANOSCALE RESEARCH LETTERS (2013)
Intravesical therapy for superficial bladder cancer: A systematic review of randomised trials and meta-analyses
Mike D. Shelley et al.
CANCER TREATMENT REVIEWS (2010)
Adjuvanticity of a synthetic cord factor analogue for subunit Mycobacterium tuberculosis vaccination requires FcRγ-Syk-Card9-dependent innate immune activation
Kerstin Werninghaus et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle
Eri Ishikawa et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia
Sho Yamasaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Molecular and supra-molecular structure related differences in toxicity and granulomatogenic activity of mycobacterial cord factor in mice
Yukiko Fujita et al.
MICROBIAL PATHOGENESIS (2007)
Intact molecular characterization of cord factor (trehalose 6,6′-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry
Y Fujita et al.
MICROBIOLOGY-SGM (2005)
Trehalose 6,6′-dimycolate (Cord factor) of Mycobacterium tuberculosis induces foreign-body- and hypersensitivity-type granulomas in mice
H Yamagami et al.
INFECTION AND IMMUNITY (2001)
Share Paper
